TY - JOUR T1 - The role of omalizumab or rhuMAb‐E25 in the treatment of allergic rhinitis JF - European Respiratory Journal JO - Eur Respir J SP - 330 LP - 330 DO - 10.1183/09031936.04.00031604 VL - 24 IS - 2 AU - D.K.C. Lee Y1 - 2004/08/01 UR - http://erj.ersjournals.com/content/24/2/330.1.abstract N2 - To the Editor: I read with interest the recent article by Hanf et al. 1, demonstrating the significant inhibition of both allergen challenge-induced nasal symptoms and the increase of human serum albumin in nasal lavage fluid after allergen challenge, in addition to the significant reduction in tumour necrosis factor‐α levels in basal nasal lavage fluid, following … ER -